Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Clinical trial NCT04016779 · COMPLETED

Trial details

NCT number: NCT04016779
Sponsor: Supernus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder (ADHD)

Start date: 2019-11-20
Primary completion: 2020-10-10
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.